NEW YORK (GenomeWeb News) – PerkinElmer has filed an action in an Ontario court seeking to block MDS' pending sale of a joint venture between the firms to Danaher.

PerkinElmer's stake in MDS's Analytical Technologies business is due to a previously signed joint venture between PerkinElmer and MDS Sciex to develop, manufacture, and sell inductively coupled plasma mass spectrometers. MDS said that this product line represents less than 10 percent of annual revenue generated by the Analytical Technologies business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.